Sources | Names Used |
---|---|
CTRPv2 | 16-beta-bromoandrosterone |
PharmacoGx | 16-beta-bromoandrosterone |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEC16A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PDPK1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | ZMYND10 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SLC8A2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | C16orf92 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | MSH4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | HS3ST6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |